Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Blue, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blue, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Myelodysplasia: Differentiating Neoplastic from Nonneoplastic Syndromes of Ineffective Hematopoiesis in Dogs

Julia T. Blue

College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, jtb2{at}cornell.edu

In the context of human hematopathology, the terms myelodysplasia and Myelodysplastic Syndromes (MDS) are applied to disorders of hematopoiesis that are clonal, neoplastic, and, in most forms, manifested as ineffective hematopoiesis with characteristic morphologic abnormalities in multiple cell lines. Studies of human patients have provided the conceptual framework that MDS evolve from a multipotential hematopoietic stem cell (CFU-GEMM) that has undergone neoplastic transformation as the result of acquired genetic mutations. The diagnosis of MDS in human patients is based largely on morphologic examination of marrow but can be confirmed by detection of cytogenetic abnormalities. Spontaneous, neoplastic myelodysplasia occurs in dogs, but rarely. Nonneoplastic syndromes of ineffective hematopoiesis are more common in dogs, can resemble MDS, and are probably immune mediated in many cases. Drugs and their metabolites are potential causes of dysmorphic maturation and ineffective hematopoiesis. Without methods to confirm clonality by cytogenetic analysis, the diagnosis of neoplastic myelodysplasia in dogs is based on light microscopic examination of bone marrow smears. This paper discusses and illustrates the characteristic morphologic and cytochemical features of neoplastic myelodysplasia and nonneoplastic ineffective hematopoiesis in dogs.

Key Words: Dogs • myelodysplastic syndromes • anemia • neutropenia • myelodysplasia • ineffective hematopoiesis.

References

  • Alleman AR, Harvey JW (1993). The morphologic effects of vincristine sulfate on canine bone marrow cells. Vet Clin Pathol 22: 36—41.
  • Bartram CR (1996). Molecular genetic aspects of myelodysplastic syndromes. Semin Hematol 33: 139—149.[Web of Science][Medline] [Order article via Infotrieve]
  • Bennett JM, Catovsky D., Daniel MT, Flandrin G., Galton DAG, Gralnick HR, Sultan C. (1982). The French-American-British Co-operative Group Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189—199.[Web of Science][Medline] [Order article via Infotrieve]
  • Blue JT, French TW, Kranz JS (1988). Non-lymphoid hematopoietic neoplasia in cats: A retrospective study of 60 cases. Cornell Vet 78: 21—42.[Web of Science][Medline] [Order article via Infotrieve]
  • Claessens Y-E., Bouscary D., Dupont J-M., Picard F., Melle J., Gisselbrecht S., Lacombe C., Dreyfus F., Mayeux P., Fontenay-Roupe M. (2002). In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: Evidence for Fas-dependent apoptosis. Blood 99: 1594—1601.[Abstract/Free Full Text]
  • Couto CG, Kallet AJ (1984). Preleukemic syndrome in a dog. J Am Vet Med Assoc 184: 1389—1392.[Web of Science][Medline] [Order article via Infotrieve]
  • Deldar A., Lewis H., Bloom J., Weiss L. (1988). Cephalosporin-induced changes in the ultrastructure of canine bone marrow. Vet Pathol 25: 211— 218.[Abstract]
  • Fenaux P., Morel P., Lai JL (1996). Cytogenetics of myelodysplastic syndromes. Semin Hematol 33: 127—138.[Web of Science][Medline] [Order article via Infotrieve]
  • Harris NL, Jaffe ES, Diebold J., Flandrin G., Muller-Hermelink HK, Vardiman J., Lister TA, Bloomfield CD (1999). World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835—3849.[Abstract/Free Full Text]
  • Harvey JW, Wolfshelmer KJ, Simpson CF, French TW (1985). Pathologic sideroblasts and siderocytes associated with chloroamphenicol therapy in a dog. Vet Clin Pathol 14: 36—42.
  • Heaney ML, Golde DW (1999). Myelodysplasia. New Engl J Med 340: 1649—1660.[Free Full Text]
  • Hisasue M., Okayama H., Okayama T., Suzuki T., Mizuno T., Fujino Y., Naganobu K., Hasegawa A., Watari T., Matsuki N., Kenichi M., Ohno K., Tsujimoto H. (2001). Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndromes. J Vet Intern Med 15: 471—477.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jacobs G., CalvertC., KaufmanA.( 1998). Neutropeniaandthrombocytopenia in three dogs treated with anticonvulsants. J Am Vet Med Assoc 212: 681— 684.[Web of Science][Medline] [Order article via Infotrieve]
  • Jain NC, Blue JT, Grindem CB, Harvey JW, Kociba GJ, Krehbiel JD, Lattimer KS, Raskin RE, Thrall MA, Zinkl JG (1991). Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Vet Clin Pathol 20: 63—82.
  • Jandl JH (1996a). Megaloblastic anemias: Drug-induced suppression of DNA synthesis. In: Blood Textbook of Hematology, 2nd ed., Little, Brown and Company, Boston, Massachusetts, pp 277—279.
  • Jandl JH (1996b). Hypochromic anemias and disorders of iron metabolism: Drug-induced sideroblastic anemias. In: Blood Textbook of Hematology, 2nd ed., Little, Brown and Company, Boston, Massachusetts, pp 308—312.
  • Lichtman MA (2000). Myelodysplasia or myeloneoplasia: Thoughts on the nosology of clonal myeloid diseases. Blood Cells Mol Dis 26: 572—581.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lorenz M., Evering WE, Provencher A., Blue JT, Lewis HB, Hazelette JR, Rajagopalan P., Meunier PC, Car BD (1999). Atypical antipsychotic-induced neutropenia in dogs. Toxicol Appl Pharmacol 155:227—236.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • McManus PM, Hess RS ( 1998). Myelodysplastic changes in a dog with subsequent acute myeloid leukemia. Vet Clin Pathol 27: 112—115.
  • Miyamoto T., Horie T., Shimada T., Kuwamura M., Baba E. (1999). Long-term case study of myelodysplastic syndrome in a dog. J Am Anim Hosp Assoc 35: 475—481.[Abstract]
  • Raskin RE (1996). Myelopoiesis and myeloproliferative disorders. Vet Clin North Am Small Anim Pract 26: 1023—1043.[Web of Science][Medline] [Order article via Infotrieve]
  • Simon SR, Branda RF, Tindle BH, Burns SL (1988). Copper deficiency and sideroblastic anemia associated with zinc ingestion. Amer J Hematol 28: 181—183.[Web of Science][Medline] [Order article via Infotrieve]
  • Stokol T., Blue JT, French TW (2000). Idopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs: 43 cases (1988—1999). J Am Vet Med Assoc 216: 1429—1436.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Weiss DJ, Aird B. ( 2001). Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog. Vet Clin Pathol 30: 67—75.
  • Weiss DJ, Lulich J. (1999). Myelodysplastic syndrome with sideroblastic differentiation in a dog. Vet Clin Pathol 28: 59—63.
  • Weiss DJ, Raskin R., Zerbe C. (1985). Myelodysplastic syndromes in two dogs. J Am Vet Med Assoc 187: 1038—1040.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 31, No. 1 suppl, 44-48 (2003)
DOI: 10.1080/01926230390177659


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Blue, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blue, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?